As the Covid-19 crisis escalates in the U.S., the scramble for an effective vaccine is about to collide with the electoral calendar. Pfizer (ticker: PFE) says it will seek Food and Drug Administration authorization for its Covid-19 vaccine as early as October. The federal government’s Covid-19 vaccine program, meanwhile, says it wants AstraZeneca’s (AZN) vaccine…